
Dogwood Therapeutics, Inc.
DWTXHealthcare|Biotechnology|US
$1.28
+0.24 (+23.08%)
DCF Value
$0.69
Cash / Share
$144984.79
Next Earnings Report
Mar 17, 2027
EPS est. -$0.16 · Revenue est. $100.0K
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Oct 30, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (1)
Dec 2026
Est. completion
P2Chemotherapy Induced Neuropathic Pain
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
NCT06848348n=240
Recent Press Releases
Dogwood Therapeutics Announces Third Quarter 2026 Financial Results
Nov 5, 2026 · GlobeNewsWire
Dogwood to Participate in the 2026 Maxim Growth Summit
Oct 6, 2026 · GlobeNewsWire
Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
Sep 14, 2026 · GlobeNewsWire
Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026
Aug 17, 2026 · GlobeNewsWire
Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
Aug 13, 2026 · GlobeNewsWire
SEC Filings (18)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Oct 30, 2026 | S-3 | Shelf registration | DocumentIndex |
| Oct 27, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 21, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Nov 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Oct 20, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 16, 2025 | S-3/A | Shelf registration | DocumentIndex |
| Oct 9, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Oct 9, 2025 | 8-K | Material event | DocumentIndex |
| Oct 8, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Oct 1, 2025 | S-3 | Shelf registration | DocumentIndex |
| Sep 29, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Sep 29, 2025 | 8-K | Material event | DocumentIndex |
| Aug 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2025 | 8-K | Material event | DocumentIndex |
| Jul 2, 2025 | 8-K | Material event | DocumentIndex |